Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04870866
PHASE2
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
Sponsor: University Hospital, Akershus
View on ClinicalTrials.gov
Summary
The study investigates the effect of dietary supplementation of nicotinamide ribonucleoside (NR) in children with ataxia telangiectasia (AT), with main focus on neurological symptoms.
Key Details
Gender
All
Age Range
3 Years - Any
Study Type
INTERVENTIONAL
Enrollment
13
Start Date
2019-06-05
Completion Date
2027-06-16
Last Updated
2022-08-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Nicotinamide ribonucleoside
Two year intervention
Locations (2)
Hilde Loge Nilsen
Lørenskog, Norway
Oslo University Hospital
Oslo, Norway